Transforming sepsis management: AI-driven innovations in early detection and tailored therapies.

Journal: Critical care (London, England)
Published Date:

Abstract

Sepsis remains a leading cause of mortality worldwide, driven by its clinical complexity and delayed recognition. Artificial intelligence (AI) offers promising solutions to improve sepsis care through earlier detection, risk stratification, and personalized treatment strategies. Key applications include AI-driven early warning systems, subphenotyping based on clinical and biological data, and decision support tools that adapt to real-time patient information. The integration of diverse data types, such as structured clinical data, unstructured notes, waveform signals, and molecular biomarkers, enhances the precision and timeliness of interventions. However, challenges such as algorithmic bias, limited external validation, data quality issues, and ethical considerations continue to hinder clinical implementation. Future directions focus on real-time model adaptation, multi-omics integration, and the development of generalist medical AI capable of personalized recommendations. Successfully addressing these barriers is essential for AI to deliver on its potential to transform sepsis management and support the transition toward precision-driven critical care.

Authors

  • Praveen Papareddy
    Department of Laboratory Medicine, Biomedical Center, Lund University, BMC C14, Lund, Sweden.
  • Thamar Jessurun Lobo
    Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Michal Holub
    Department of Infectious Diseases, First Faculty of Medicine, Charles University and Military University Hospital Prague, Prague, Czech Republic.
  • Hjalmar Bouma
    Department of Internal Medicine, Department of Acute Care, and Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, Hanzeplein 1, Groningen, 9713, Groningen, Netherlands. Electronic address: h.r.bouma@umcg.nl.
  • Jan Maca
    Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine, Institute of Physiology and Pathophysiology, University Hospital Ostrava, University of Ostrava, Ostrava, Czech Republic.
  • Nils Strodthoff
    Fraunhofer Heinrich Hertz Institute, 10587 Berlin, Germany. Author to whom any correspondence should be addressed.
  • Heiko Herwald
    Department of Laboratory Medicine, Biomedical Center, Lund University, BMC C14, Lund, Sweden. heiko.herwald@med.lu.se.